Braunschweig, Germany

Joerg Lauber

This inventor holds 1 USPTO granted patent. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2005.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joerg Lauber: Innovator in Recombinant Human Cell Technology

Introduction

Joerg Lauber is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of recombinant human cells for medical applications. His work focuses on advancing the understanding and treatment of bone and cartilage-related conditions.

Latest Patents

Lauber holds a patent for a recombinant human cell that is instrumental in bone and cartilage cell formation. This invention relates to a recombinant human cell of undifferentiated mesenchyma, which possesses the ability to express Tbr-1, Brachyury, or another member of the T-box family. This innovative approach has the potential to enhance regenerative medicine and tissue engineering.

Career Highlights

Throughout his career, Joerg Lauber has been associated with the Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work has been pivotal in bridging the gap between research and practical applications in the medical field. Lauber's dedication to innovation has positioned him as a key figure in his area of expertise.

Collaborations

Lauber has collaborated with esteemed colleagues, including Stefan Czichos and Hubert Mayer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Joerg Lauber's contributions to recombinant human cell technology exemplify the impact of innovative thinking in biotechnology. His work not only advances scientific knowledge but also holds promise for future medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…